We are live on ! Find out more
PC

Paulson & Co Portfolio holdings

AUM $3.11B
1-Year Est. Return 94.93%
This Fund
S&P 500
This Quarter Est. Return
-8.04%
1 Year Est. Return
+94.93%
3 Year Est. Return
+233.32%
5 Year Est. Return
+258.51%
10 Year Est. Return
+934.97%
AUM
$13.5B
AUM Growth
-$3.2B
Cap. Flow
-$894M
Cap. Flow %
-6.61%
Top 10 Hldgs %
61.27%
Holding
107
New
30
Increased
23
Reduced
29
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 51.8%
2 Communication Services 8.32%
3 Consumer Discretionary 7.39%
4 Financials 5.78%
5 Real Estate 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAD
76
DELISTED
Rite Aid Corporation
RAD
$2.15M 0.02%
+13,175
New +$2.08M
ARG
77
DELISTED
Airgas Inc
ARG
$2.11M 0.02%
+14,900
New +$2.09M
RIGL icon
78
Rigel Pharmaceuticals
RIGL
$712M
$2.08M 0.02%
99,970
+47,100
+89% +$1.16M
PBYI icon
79
Puma Biotechnology
PBYI
$406M
$2.06M 0.02%
70,300
+24,300
+53% +$1.1M
BHC icon
80
CALL
Bausch Health
BHC
$1.69B
$1.92M 0.01%
+73,100
New +$5.41M
BAC.WS.B
81
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$1.79M 0.01%
8,960,537
-26,263
-0.3% -$5.52K
ESPR
82
DELISTED
Esperion Therapeutics
ESPR
$1.73M 0.01%
102,000
+79,500
+353% +$1.28M
ITC
83
DELISTED
ITC HOLDINGS CORP
ITC
$1.64M 0.01%
+37,600
New +$1.53M
SNDK
84
DELISTED
SANDISK CORP
SNDK
$1.58M 0.01%
+20,800
New +$1.5M
BSX icon
85
Boston Scientific
BSX
$68.5B
$1.39M 0.01%
+74,000
New +$1.3M
IM
86
DELISTED
Ingram Micro
IM
$1.04M 0.01%
+29,100
New +$931K
ALNY icon
87
Alnylam Pharmaceuticals
ALNY
$38.5B
$772K 0.01%
12,300
BCRX icon
88
BioCryst Pharmaceuticals
BCRX
$2.48B
$745K 0.01%
+263,100
New +$1.17M
OSG
89
DELISTED
Overseas Shipholding Group Inc.
OSG
$509K ﹤0.01%
+45,140
New +$624K
CLDX icon
90
Celldex Therapeutics
CLDX
$2.79B
$268K ﹤0.01%
+4,720
New +$531K
DXM
91
DELISTED
DEX MEDIA INC NEW COM STK (DE)
DXM
$121K ﹤0.01%
1,347,437
ARDM
92
DELISTED
Aradigm Corp Common Stock
ARDM
$87K ﹤0.01%
+19,662
New +$67.9K
CYH icon
93
PUT
Community Health Systems
CYH
$393M
$53K ﹤0.01%
+423,500
New +$6.46M
SU icon
94
Suncor Energy
SU
$75.4B
$3K ﹤0.01%
100
ABBV icon
95
AbbVie
ABBV
$465B
-139,700
Closed -$8.28M
BKNG icon
96
Booking.com
BKNG
$154B
-22,500
Closed -$1.15M
GMED icon
97
Globus Medical
GMED
$10.9B
-132,300
Closed -$3.68M
LH icon
98
Labcorp
LH
$25.8B
-27,470
Closed -$2.92M
OUT icon
99
Outfront Media
OUT
$5.72B
-4,353,454
Closed -$93.5M
NUVA
100
DELISTED
NuVasive, Inc.
NUVA
-31,800
Closed -$1.72M

Similar funds

Paulson & Co's Q1 2016 Portfolio in Review

As of Q1 2016, Paulson & Co held 107 positions worth $13.5B, down 19% from $16.7B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Paulson & Co withdrew a net $894M in Q1 2016, closing 10 positions and reducing 29 holdings. Its most notable exit was Outfront Media, an estimated $93.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 55% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Paulson & Co opened a new position in B/E Aerospace Inc worth $138M.

  • Paulson & Co's largest Q1 2016 buy was B/E Aerospace Inc: 3,000,000 shares worth $138M.
  • Paulson & Co added most to Endo International plc in Q1 2016, an estimated $294M increase.
  • Paulson & Co's biggest Q1 2016 reduction was TIME WARNER CABLE INC NEW COM STK, cutting an estimated $768M.
  • Paulson & Co fully exited Outfront Media in Q1 2016, selling an estimated $93.5M.
  • Paulson & Co's ten largest holdings make up 61% of its $13.5B portfolio in Q1 2016.
  • Paulson & Co opened 30 new positions and closed 10 in Q1 2016.
  • Paulson & Co's portfolio value fell 19% quarter-over-quarter to $13.5B.

Based on Paulson & Co's 13F filing for Q1 2016, filed 16 May 2016.